CURATODERM
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TACALCITOL 4.17 MCG/G
Available from:
NEOPHARM LTD
ATC code:
D05AX04
Pharmaceutical form:
OINTMENT
Administration route:
TOPICAL
Manufactured by:
ALMIRALL HERMAL GMBH, GERMANY
Therapeutic group:
TACALCITOL
Therapeutic indications:
Psoriasis vulgaris. The treatment should not exceed consecutive period of 8 weeks at a maximum of 2 such periods in 12 months
Authorization date:
2009-12-01
